A18.39 Retroperitoneal tuberculosis

Name of the Condition

• Retroperitoneal tuberculosis
• ICD Code: A18.39

Summary

Retroperitoneal tuberculosis is a form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects the retroperitoneal space, which includes the area behind the peritoneum containing organs like the kidneys, pancreas, and major blood vessels. This condition typically results from the spread of TB bacteria from a primary site, usually the lungs, via the bloodstream or lymphatic system. It can involve inflammation of retroperitoneal tissues, leading to localized or systemic symptoms.

Causes

Retroperitoneal tuberculosis is caused by the dissemination of Mycobacterium tuberculosis from an existing infection, most commonly pulmonary tuberculosis. The bacteria may travel to the retroperitoneal region during active disease or reactivation of latent TB. Direct ingestion of infected material is rare but possible in certain cases.

Risk Factors

• Immunocompromised states, such as HIV/AIDS or chronic immunosuppressive therapy.
• History of untreated or inadequately treated tuberculosis.
• Close contact with individuals who have active TB.
• Living in or traveling to regions with high TB prevalence.
• Underlying conditions like diabetes, malnutrition, or chronic kidney disease.

Symptoms

• Abdominal or back pain.
• Fever, chills, or night sweats.
• Unintentional weight loss.
• Fatigue or malaise.
• Nausea, vomiting, or loss of appetite.
• Abdominal mass or swelling.

Diagnosis

Diagnosis of retroperitoneal tuberculosis involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI), and laboratory tests. Imaging may reveal retroperitoneal lymphadenopathy, abscesses, or tissue thickening. Laboratory tests include sputum or tissue cultures, nucleic acid amplification tests (NAATs), and histopathological examination of biopsy samples to detect Mycobacterium tuberculosis. A definitive diagnosis often requires tissue biopsy and microbiological confirmation.

Treatment Options

Treatment typically follows standard antitubercular therapy (ATT) regimens, including a combination of first-line drugs like isoniazid, rifampin, pyrazinamide, and ethambutol for an initial intensive phase, followed by a continuation phase. Duration of therapy is usually 6–9 months, depending on disease severity and response. Surgical intervention may be necessary for complications like abscess drainage or tissue biopsy.

Prognosis and Follow-Up

With appropriate treatment, the prognosis for retroperitoneal tuberculosis is generally favorable, though outcomes depend on early diagnosis, adherence to therapy, and underlying health status. Follow-up includes monitoring for treatment response, symptom resolution, and potential drug toxicity. Regular clinical and imaging assessments may be required to ensure complete recovery and detect relapse.

Complications

• Retroperitoneal fibrosis or scarring.
• Organ dysfunction (e.g., renal or vascular involvement).
• Abscess formation or fistula development.
• Drug resistance if treatment is incomplete or inadequate.
• Systemic dissemination of TB.

Lifestyle & Prevention

• Complete the full course of prescribed antitubercular therapy.
• Maintain good nutrition and hydration to support immune function.
• Avoid close contact with individuals who have active TB until non-infectious.
• Follow infection control measures in healthcare settings.
• Screen for latent TB in high-risk populations and treat as indicated.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe abdominal pain, high fever, unexplained weight loss, or signs of systemic infection. Prompt evaluation is critical for early diagnosis and treatment to prevent complications.

Tips for Medical Coders

Code A18.39 is used for retroperitoneal tuberculosis, a specific site of extrapulmonary TB. Documentation should specify the retroperitoneal location and confirm the diagnosis through clinical, imaging, or laboratory findings. Ensure differentiation from other retroperitoneal infections or conditions to support accurate coding.